120 related articles for article (PubMed ID: 9506438)
21. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
22. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
23. Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase.
Straume O; Smeds J; Kumar R; Hemminki K; Akslen LA
Am J Pathol; 2002 Jul; 161(1):229-37. PubMed ID: 12107107
[TBL] [Abstract][Full Text] [Related]
24. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
[TBL] [Abstract][Full Text] [Related]
25. Analysis of losses of heterozygosity of the candidate tumour suppressor gene DMBT1 in melanoma resection specimens.
Deichmann M; Mollenhauer J; Helmke B; Thome M; Hartschuh W; Poustka A; Näher H
Oncology; 2002; 63(2):166-72. PubMed ID: 12239452
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity at polymorphic chromosomal loci in patients with malignant melanoma.
Orita M; Murakami Y; Ishihara K; Sekiya T
J Invest Dermatol; 1989 May; 92(5 Suppl):280S-283S. PubMed ID: 2565933
[TBL] [Abstract][Full Text] [Related]
27. Analysis of tumor cell evolution in a melanoma: evidence of mutational and selective pressure for loss of p16ink4 and for microsatellite instability.
Rübben A; Babilas P; Baron JM; Hofheinz A; Neis M; Sels F; Sporkert M
J Invest Dermatol; 2000 Jan; 114(1):14-20. PubMed ID: 10620109
[TBL] [Abstract][Full Text] [Related]
28. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36.
Poetsch M; Dittberner T; Woenckhaus C
Oncogene; 2002 May; 21(19):3038-42. PubMed ID: 12082534
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity detected on 1p and 9q in microdissected atypical nevi.
Böni R; Zhuang Z; Albuquerque A; Vortmeyer A; Duray P
Arch Dermatol; 1998 Jul; 134(7):882-3. PubMed ID: 9681364
[No Abstract] [Full Text] [Related]
30. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
Zainuddin N; Jaafart H; Isa MN; Abdullah JM
Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
[TBL] [Abstract][Full Text] [Related]
31. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
[TBL] [Abstract][Full Text] [Related]
32. Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma.
Fujimoto A; Takeuchi H; Taback B; Hsueh EC; Elashoff D; Morton DL; Hoon DS
Cancer Res; 2004 Mar; 64(6):2245-50. PubMed ID: 15026369
[TBL] [Abstract][Full Text] [Related]
33. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
Parris CN; Harris JD; Griffin DK; Cuthbert AP; Silver AJ; Newbold RF
Cancer Res; 1999 Feb; 59(3):516-20. PubMed ID: 9973191
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
[TBL] [Abstract][Full Text] [Related]
35. Morphologic diversity in malignant melanoma: the potential use of microdissection and the polymerase chain reaction for diagnosis.
Quezado MM; Abati AD; Albuquerque AV; Wilson J; Merino MJ; Filie AC
Mod Pathol; 1998 Oct; 11(10):1010-5. PubMed ID: 9796732
[TBL] [Abstract][Full Text] [Related]
36. Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma.
Herbst RA; Gutzmer R; Matiaske F; Mommert S; Casper U; Kapp A; Weiss J
Int J Cancer; 1999 Jan; 80(2):205-9. PubMed ID: 9935201
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
39. Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification.
Dopierala J; Damato BE; Lake SL; Taktak AF; Coupland SE
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4898-905. PubMed ID: 20484589
[TBL] [Abstract][Full Text] [Related]
40. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma.
Fujimoto A; Morita R; Hatta N; Takehara K; Takata M
Oncogene; 1999 Apr; 18(15):2527-32. PubMed ID: 10229204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
